Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JONATHAN HERO CHUNG

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1508878752
CMS profile
918590
Location
SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$165,849.37

50 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $123,165.00 29
Boehringer Ingelheim Pharmaceuticals, Inc. $32,197.08 14
AstraZeneca UK Limited $4,387.29 2
ABBVIE INC. $3,850.00 4
BeiGene USA, Inc. $2,250.00 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

50 matching records · $165,849.37 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 50 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 50.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $550.0012/09/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103132931 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $4,875.0011/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039120 CMS
Daiichi Sankyo Inc. $18,296.2510/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409392 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.0010/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039100 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.0010/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039108 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12,000.0010/17/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039122 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $123.8609/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039098 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $767.1009/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039102 CMS
Daiichi Sankyo Inc. $2,975.0009/18/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409382 CMS
Daiichi Sankyo Inc. $3,421.2509/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409362 CMS
Daiichi Sankyo Inc. $2,677.5009/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409370 CMS
Daiichi Sankyo Inc. $3,570.0009/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409378 CMS
BeiGene USA, Inc. $2,250.0009/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120866968 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,375.0008/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039116 CMS
AstraZeneca UK Limited $3,490.5008/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261093997927 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $48.9808/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039110 CMS
Daiichi Sankyo Inc. $2,975.0008/07/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409358 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $116.4207/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039096 CMS
Daiichi Sankyo Inc. $7,288.7507/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409380 CMS
Daiichi Sankyo Inc. $1,041.2507/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409394 CMS
Daiichi Sankyo Inc. $6,693.7507/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409400 CMS
Daiichi Sankyo Inc. $2,826.2507/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409372 CMS
Daiichi Sankyo Inc. $3,570.0006/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409374 CMS
Daiichi Sankyo Inc. $4,611.2506/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409376 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,750.0006/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039118 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $100.2906/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039112 CMS
ABBVIE INC. $550.0006/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103132929 CMS
ABBVIE INC. $1,650.0005/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103132925 CMS
ABBVIE INC. $1,100.0005/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103132927 CMS
Daiichi Sankyo Inc. $3,570.0005/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409350 CMS
Daiichi Sankyo Inc. $3,570.0005/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409360 CMS
Daiichi Sankyo Inc. $3,718.7505/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409398 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,375.0005/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039106 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,375.0005/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039104 CMS
Daiichi Sankyo Inc. $3,867.5005/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409346 CMS
Daiichi Sankyo Inc. $4,313.7505/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409366 CMS
Daiichi Sankyo Inc. $2,677.5005/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409364 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $115.4304/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118039114 CMS
Daiichi Sankyo Inc. $3,421.2504/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409388 CMS
Daiichi Sankyo Inc. $3,421.2504/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409396 CMS
Daiichi Sankyo Inc. $4,462.5003/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409384 CMS
Daiichi Sankyo Inc. $2,528.7503/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409386 CMS
Daiichi Sankyo Inc. $3,570.0003/06/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409348 CMS
AstraZeneca UK Limited $896.7902/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261093977626 CMS
Daiichi Sankyo Inc. $3,421.2502/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409352 CMS
Daiichi Sankyo Inc. $5,652.5002/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409368 CMS
Daiichi Sankyo Inc. $2,677.5002/07/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409356 CMS
Daiichi Sankyo Inc. $5,801.2502/07/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409402 CMS
Daiichi Sankyo Inc. $3,272.5001/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409354 CMS
Daiichi Sankyo Inc. $3,272.5001/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089409390 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $72,282.14 50
PY2020 $32,849.47 10
PY2021 $26,625.75 16
PY2022 $94,470.39 38
PY2023 $167,586.85 63
PY2024 $165,849.37 50
PY2025 $187,281.78 98

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
JONATHAN HERO CHUNG, NPI 1508878752. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1508878752.
APA 7
IndustryPayments. (2026). JONATHAN HERO CHUNG, NPI 1508878752 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1508878752
Bluebook
JONATHAN HERO CHUNG, NPI 1508878752, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1508878752.

Source: Centers for Medicare & Medicaid Services, Open Payments.